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The Streptococcus mutans serotype c gtfA gene encodes a 55-kilodalton protein which catalyzes the synthesis
of a small glucan (1.5 kilodaltons) from sucrose (J. P. Robeson, R. G. Barletta, and R. Curtiss III, J. Bacteriol.
153:211-221, 1983). To investigate the role of the GtfA enzyme in virulence, we constructed S. mutans gtfA
mutants from three cariogenic serotype c strains. A plasmid that carried an erythromycin resistance
determinant and an internal fragment of the gtfA gene but that was unable to replicate in streptococci was used
to transform S. mutans. The erythromycin-resistant transformants carried a partial duplication of the internal
gtfA fragment, because of the integration of plasmid sequences within the S. mutans gtfA gene, which also
resulted in the inactivation of the gtfA gene. This was verified by Southern DNA hybridization analysis and
Western blot studies of cellular protein extracts of the mutant strains with GtfA antiserum. Mutants were fully
virulent in both germfree and conventional rats. These results do not rule out the involvement of the GtfA
protein in virulence. Pucci and Macrina (M. J. Pucci and F. L. Macrina, Infect. Immun. 54:77-84, 1986) have
suggested that the GtfA enzyme synthesizes a primer for water-insoluble glucans. Another S. mutans protein,
presumably a glucosyltransferase, may have a similar function and, thus, may obscure the relevance of the
GtfA enzyme in pathogenesis.
Sucrose metabolism plays a critical role in caries forma-
tion by Streptococcus mutans (35). S. mutans produces a
battery of extracellular, cell surface-associated, and cyto-
plasmic enzymes that are involved in sucrose metabolism.
Glucosyltransferases (EC 2.4.1.5) catalyze glucan formation
with sucrose as the substrate (19, 25, 47), with the corre-
sponding release of free fructose. Fructosyltransferases (EC
2.4.1.10) polymerize the fructosyl moiety of sucrose and
release free glucose (7). Extracellular invertase (EC 3.2.1.26)
directly hydrolyzes sucrose to glucose and fructose (8, 19).
Other enzymes involved in sucrose metabolism are those in
the phosphotransferase system, an enzyme complex that is
involved in sucrose transport and phosphorylation that
works in concert with sucrose-6-phosphate hydrolase (9, 48,
49).
Glucosyltransferases are thought to be the most important
enzymes involved in S. mutans colonization of the oral
cavity. Enzyme activities involved in the synthesis of water-
soluble glucans have been referred to as dextransucrases,
since these glucans have a preponderance of a-(1,6)-glu-
tosidic linkages and, hence, a structure similar to that of
dextran molecules (17). Water-soluble glucans provide a
weak attachment force for the adherence and aggregation of
bacteria (45). The name mutansucrase has been proposed for
the enzyme(s) that is responsible for the synthesis of water-
insoluble glucans (52), with a majority of a-(1,3)-glucosidic
linkages and a highly branched structure (17). Interactions
that are mediated by water-insoluble glucans allow the
bacteria to be firmly attached (45).
We have previously identified a S. mutans glucosyltrans-
ferase, the glucosyltransferase A (GtfA) enzyme, by cloning
* Corresponding author.
t Present address: Department of Microbiology and Immunology,
Albert Einstein School of Medicine, Bronx, NY 10461.
a gene into Escherichia coli (44). The S. mutans serotype c
gtfA gene encodes a 55-kilodalton (kDa) protein and has
been cloned in the E. coli plasmid vector pBR322 (44). The
recombinant plasmid (designated pYA601) has a 1.7-kilobase
(kb) S. mutans chromosomal DNA insert that encodes the
structural and regulatory sequences for the gtfA gene. More
recently, the serotype e allele also has been cloned in E. coli
with additional flanking sequences (42, 43). The genes from
serotypes c and e are identical. The GtfA enzyme purified
from E. coli recombinant clones catalyzes the synthesis of a
small glucan (1.5 kDa) from sucrose (44). The GtfA protein is
probably bound to the S. mutans cytoplasmic membrane
(44), and its role in glucan formation is different from the
roles of other extracellular glucosyltransferases (1, 26) that
are involved in the synthesis of high-molecular-weight glu-
cans. We first hypothesized that the GtfA glucan could be a
primer for the synthesis of these larger products (44). Intro-
duction of the S. mutans gtfA gene into S. sanguis altered
the structure of the glucans that were produced; they went
from being water soluble to being water insoluble (42).
Results of further studies with S. mutans serotype c gtfA
deletion mutants suggest that the GtfA enzyme makes a
glucan primer for the synthesis of water-insoluble glucans
(43).
In spite of the extensive biochemical analysis of the GtfA
enzyme described above, however, there is no clear picture
about the role and importance of the GtfA enzyme in the
colonization of the oral cavity by S. mutans. If the glucan
primer synthesized by the GtfA enzyme is involved in
adherence and aggregation (by itself or as the precursor for
a larger-molecular-weight glucan), we expect that the S.
mutans gtfA mutants would have reduced virulence. To
investigate the role of the S. mutans gtfA gene in virulence,
we constructed S. mutans gtfA mutants from various cario-
genic serotype c strains using an insertion-duplication strat-
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S. MUTANS gtfA MUTANTS 323
egy. In this report we describe the construction, character-
ization, and evaluation of the virulence of S. mutans gtfA
mutants in germfree and conventional rats. Our findings
indicate that the GtfA enzyme is not a major virulence
determinant.
(A preliminary account of these findings was presented at
the 87th Annual Meeting of the American Society for Micro-
biology [R. G. Barletta, S. M. Michalek, and R. Curtiss III,
Abstr. Annu. Meet. Am. Soc. Microbiol. 1987, D77, p. 84].)
MATERIALS AND METHODS
Bacterial strains and growth media. The bacterial strains
used in this study are listed in Table 1. Growth of E. coli and
S. mutans, complex media or their components (Difco
Laboratories, Detroit, MI), defined media, nutritional sup-
plements, and antibiotics (Sigma Chemical Co., St. Louis,
Mo.) are described in the text or have been described
elsewhere (44).
Preparation of DNA. Overnight cultures of S. mutans
strains in brain heart infusion (BHI) broth were diluted
100-fold into 250 ml of the same medium and incubated for 20
h at 37°C in standing conditions. Cells were harvested and
suspended in 5 ml of TE buffer (10 mM Tris hydrochloride,
1 mM EDTA) [pH 7.5]), which contained 20 mg of lysozyme
(Sigma) per ml and 0.5 mg of mutanolysin powder (Sigma)
per ml. The cell suspension was incubated for 1 h at 37°C.
Pronase (Calbiochem-Behring, La Jolla, Calif.) was added
(approximately 2.5 mg), and the suspension was further
incubated for 30 min at 37°C. Cells were lysed by adding
sodium dodecyl sulfate (SDS) at a 5% (wt/vol) final concen-
tration (J. Galan, personal communication). Total DNA was
then purified by centrifugation in CsCl gradients with a rotor
(TFT65.13; Du Pont Co., Wilmington, Del.) run in an
ultracentrifuge (Sorvall OTD65; (Du Pont Co.). Plasmid
DNA from E. coli strains was isolated by an alkaline lysis
procedure, followed by centrifugation in CsCI-ethidium bro-
mide gradients (33). All DNA samples were dialyzed against
and stored in TE buffer (pH 8.0).
Preparation of crude protein extracts. Cells were grown
overnight in 0.5 liters of tryptic soy broth, harvested by
centrifugation, suspended in 8.0 ml of 25 mM sodium phos-
phate buffer (pH 6.8), and treated with 2,500 U of mutanoly-
sin at 37°C for 2 h. The resulting cell suspension was mixed
with acid-washed glass beads (diameter, 150 to 200 ,um;
Sigma) at one-third the volume of the original cell suspension
and disrupted in a cell homogenizer (MSK; B. Braun Mel-
sungen AG, Melsungen, Federal Republic of Germany) at
maximum speed for 2 min. The chamber temperature was
kept at 1 to 10°C by an intermittent stream of CO2. After
centrifugation (10,000 rpm for 10 min in a rotor [SS34
TABLE 1. Bacterial strains used in this study
Strain Phenotype or genotype, plasmid sizea Source or reference
E. coli K-12
X1849 F- JhuA53 dapD8 minAl purE41 ginV42 A40(gal-uvrB) X- minB2 his53 21
nalA25 metC65 oms-l A29(bioH-asd) ilv-277 cycB2 cycAl hsdR2 Ems
X1849(pYA301) As for strain X1849, with pYA301; Emr Tcr; 5.5 kb R. J. Cook and R. G. Barletta,
unpublished data
X1849(pYA601) As for strain X1849, with pYA601; GtfA+ Apr; 6.1 kb 44
X1849(pYA627) As for strain X1849, with pYA627; Apr Emr; 6.1 kb 39
X1849(pYA682) As for strain X1849, with pYA682; plasmid carries truncated 1.36-kb N This study
terminus-coding sequence of gtfA gene; Apr Emr; 7.8 kb
X1849(pYA689) As for strain X1849, with pYA689; plasmid carries internal fragment of This study
gtfA gene; Emr Tcr; 5.6 kb
x2970 F- fhuA53 dapD8 minAl purE41 ginV42 A40(gal-uvrB) X- minB2 hisS3 R. G. Barlettab
nalA25 Srl- recA56 metC65 oms-i ilv277 cycB2 cycAl hisdR2 Ems
X2970(pYA302) As for strain X2970, with pYA302; Emr Tcr; 5.5 kb R. J. Cook and R. G. Barletta,
unpublished data
X2970(pYA69O) As for strain X2970, with pYA690; plasmid carries internal fragment of This study
gtfA gene; Emr Tcr; 5.6 kb
S. mutans
GS5 Serotype c; Ems GtfA+ H. Kuramitsuc
MT8148 Serotype c; rough; Ems GtfA+ 41
MT8148(pYA629) As for strain MT8148, with pYA629; plasmid replicates in E. coli and 39
S. mutans; Emr (in S. mutans); 11.2 kb
UA101 Serotype c; rough; Ems GtfA+ P. Caufield, 39
UA130 Serotype c; smooth; Ems GtfA+ P. Caufield, 39
UAB62 Serotype c; Ems GtfA+ 38
UAB90 Serotype c; Ems GtfA+ 38
UAB744 Serotype c; rough; gtfA Emr; transformant of UA101 with pYA689 This study
UAB746 Serotype c; rough; gtfA Emr; transformant of UA101 with pYA690 This study
UAB747 Serotype c; rough; gtfA Emr; transformant of UA130 with pYA689 This study
UAB751 Serotype c; smooth; gtfA Emr; transformant of UA130 with pYA690 This study
UAB754 Serotype c; smooth; gtfA Emr; transformant of MT8148 with pYA689 This study
UAB755 Serotype c; smooth; gtfA Emr; transformant of MT8148 with pYA690 This study
UAB764 Serotype c; smooth spontaneous mutant of MT8148; Ems This study
a Rough or smooth phenotype refers to the colony morphology on BHI agar plates after 48 h of incubation at 37°C under anaerobic conditions. It is indicated
for identification purposes and does not correlate with the other described traits.
b Ph.D. thesis, University of Alabama at Birmingham, 1987.
Department of Microbiology, Northwestern University Medical School, Chicago, Ill.d School of Dentistry, University of Alabama at Birmingham, Birmingham, Ala.
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324 BARLETTA ET AL.
Sorvall; Du Pont]), the supernatant fluids were used as a
source of intracellular and membrane protein fractions.
Transformation of bacterial strains. E. coli strains were
transformed by a KCI-CaCI2 transformation protocol as
described previously (44), with slight modifications. Briefly,
cells were harvested at an optical density at 600 nm between
0.1 to 0.2, and the cell pellet was suspended in one-fourth the
original volume in 25 mM KCI-10 mM Tris hydrochloride
(pH 8.0) and incubated on ice for 10 min. Cells were then
pelleted, suspended in one-fourth the original volume in 100
mM CaCI2-10 mM Tris hydrochloride (pH 8.0), and incu-
bated on ice for 10 min. Cells were pelleted and concentrated
400-fold from the original cell density in 67 mM CaCl2-10
mM Tris hydrochloride (pH 8.0). Routinely, 100 ng of DNA
was mixed with 0.1 ml of the cell suspension in each
transformation experiment. Transformants were selected on
appropriately supplemented L-agar (29) plates containing 25
to 50 pug of ampicillin per ml, 12.5 to 25 pg of tetracycline per
ml, or 500 ,ug of erythromycin per ml. Direct selection of
erythromycin-resistant (Em') transformants required ap-
proximately 10 h of phenotypic lag. Transformants were
then selected on plates with ampicillin or tetracycline and
screened for erythromycin resistance. Transformation of S.
mutans was carried out as described previously (39). Rou-
tinely, 5 to 10 p.g of plasmid DNA suspended in a minimum
volume of TE buffer (pH 8.0) was mixed with 1.0 ml of an
exponentially growing S. mutans culture of Todd-Hewitt
broth supplemented with 5% horse serum (GIBCO Labora-
tories, Grand Island, N.Y.). Erythromycin was added to the
broth culture at 75 ng/ml to induce resistance in S. mutans
during phenotypic expression, and transformants were se-
lected on BHI agar containing 1 to 25 ,ug of erythromycin per
ml.
Restriction enzyme digestion and DNA ligations. Digestion
with restriction enzymes (Bethesda Research Laboratories,
Gaithersburg, Md.; International Biotechnologies Inc., New
Haven, Conn.; New England BioLabs, Inc., Beverly,
Mass.; Promega Biotec, Madison, Wis.) was performed as
recommended by the suppliers or as described by Davis et
al. (14). Intermolecular T4 DNA ligase reactions of a linear-
ized plasmid vector to a linearized insert were performed to
maximize production of recombinant circular molecules by
using DNA concentrations that were determined by the
following conditions: (i) ends per milliliter of vector = ends
per milliliter of insert, and (ii) j (Jacobson-Stockmayer
factor) insert per total number of ends = 1.5 (15, 28; Focus,
vol. 2, Bethesda Research Laboratories).
Gel electrophoresis. DNA was subjected to electrophoresis
in 0.8% horizontal agarose (ultrapure; Bethesda Research
Laboratories) or 5% vertical polyacrylamide gels. The run-
ning buffer was 40 mM Tris, 5 mM sodium acetate, and 1 mM
sodium EDTA (22) adjusted to pH 7.6 with glacial acetic
acid. Gels were stained with a solution of 2 ,ug of ethidium
bromide (Sigma) per ml. Reference DNA fragments for size
determinations were phage X DNA digested with HindIlI or
4PX174 (replicative form) digested with HaeIII (Bethesda
Research Laboratories).
Recovery of DNA from gels. Agarose gel slices with the
band of interest were placed inside dialysis bags (Spectrum
Medical Industries, Inc., Los Angeles, Calif.) containing
running buffer and electrophoresed at 100 to 150 V for 1 h
(33). The direction of the electrical current was then re-
versed for 30 to 60 s, and the buffer containing the DNA from
the dialysis bag was saved. Small particles of agarose were
removed by filtration through cellulose acetate filters (pore
size, 0.5 ,um; Nalgene Labware Div., Nalge/Sybron Corp.,
Rochester, N.Y.). The DNA was further purified by extrac-
tion with organic reagents: once with an equal volume of
TE-saturated phenol and twice with chloroform. Recovery
of DNA fragments from polyacrylamide gels was done as
described previously (33).
DNA blotting and hybridization procedures. Transfer of
DNA fragments from electrophoresis gels to GeneScreen
Plus (New England Nuclear Corp., Boston, Mass.) was
carried out by a capillary blot procedure as recommended by
the supplier. The membranes were prehybridized at 42°C
overnight, and the hybridization reaction was allowed to
proceed at 42°C for three C0t112 periods in a buffer containing
6x SSC (0.9 M NaCl plus 0.09 M sodium citrate), 0.5% SDS,
50% formamide, 0.1% Ficoll (Pharmacia Fine Chemicals,
Piscataway, N.J.), 0.1% polyvinylpyrrolidone, 0.1% bovine
serum albumin, 100 ,ug of denatured salmon sperm DNA per
ml, and 0.1 ,ug of DNA probe per ml (ca. 108 dpm/,ug) labeled
with [32P]dATP (Amersham Corp., Arlington Heights, Ill.)
by nick translation. Hybridization and washes were per-
formed in a processing system (OmniBlot; American Bione-
tics Inc., Emeryville, Calif.). Membranes were washed with
0.25 liters of 2x SSC-0.5% SDS at room temperature for 15
min, 1 liter of3x SSC-0.1% SDS at 65°C, and 1 liter of0.3x
SSC-0.1% SDS at 65°C (G. Jen, personal communication).
Membranes were finally washed briefly with 0.25 liters of 3 x
SSC-0.1% SDS at room temperature, dried, and autoradio-
graphed with XAR-5 film (Eastman Kodak Co., Rochester,
N.Y.).
Western blots. Cell extracts were electrophoresed in 10%
reducing and denaturing SDS-polyacrylamide gels by using
the discontinuous buffer system described by Laemmli and
Favre (27). Proteins were then transferred to pure nitrocel-
lulose sheets (pore size, 0.45 ,um; Schleicher & Schuell, Inc.,
Keene, N.H.) (51) by using a electrophoresis unit (Trans-
phor; Hoefer Scientific Instruments, San Francisco, Calif.)
and applying 180 mA for 12 to 16 h at 4°C. Transfer buffer
was 25 mM Tris base, 192 mM glycine, and 20% methanol.
Procedures were then carried out at room temperature. The
nitrocellulose sheets were washed briefly in TAW buffer (0.1
M Tris hydrochloride [pH 8.0], 0.05% sodium azide, 0.04%
Tween 80); the remaining reactive sites were then blocked
with a 0.25% bovine serum albumin-0.25% gelatin solution
in TAW buffer (blocking buffer) for at least 1 h. Then, a
1,000-fold dilution of rabbit GtfA antiserum that was ab-
sorbed with a wild-type E. coli cell extract was added to the
nitrocellulose and incubated for at least 6 h. The sheets were
then washed three times with TAW buffer and incubated
with a 3,000-fold dilution of a goat anti-rabbit immunoglob-
ulin G alkaline phosphatase conjugate (Sigma) that was
previously absorbed with an E. coli extract. The sheets were
washed three times with TAW buffer-0.5% SDS; the final
wash and histochemical development of alkaline phospha-
tase activity were performed as described previously (5).
The washing steps were adapted from similar procedures
(51; R. Goldschmidt, personal communication). Size stan-
dards for SDS-polyacrylamide protein gels were a mixture of
prestained proteins ranging from 26,600 to 180,000 kDa
(stock no. SDS-7B; Sigma).
Gnotobiotic and conventional rat studies. The virulence of
S. mutans strains was determined in both gnotobiotic and
conventional Fischer rats. Weanling gnotobiotic or conven-
tional rats (age, 19 to 20 days) were challenged orally with a
swab that was saturated with a log-phase BHI culture
(approximately 2 x 108 CFU/ml) of the appropriate test S.
mutans, and provided diet 305 ad libitum as described
previously (34). Rats were sacrificed at 45 days of age for
INFECT. IMMUN.
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S. MUTANS gtfA MUTANTS 325
gnotobiotic rats and at 55 days of age for conventional rats
(infection time for conventional rats was extended to ensure
adequate time for caries to develop), and plaque microbiol-
ogy and caries scores were determined (34). The researcher
who evaluated the caries scores did not have previous
knowledge of the characteristics of the strains being tested.
RESULTS
Construction of a plasmid with an internal fragment of the
gtfA gene and a marker selectable in streptococci. Plasmid
pYA601 carries the gtfA gene within a 1.73-kb insert that is
cut by HindIII into 1.36- and 0.37-kb fragments (44). Since
the 1.36-kb HindIII fragment did not encode a functional
GtfA enzyme (44) (see below), this HindIII site should be
internal to the gtfA gene. EcoRV cuts the 1.36-kb fragment
into 1.1- and 0.26-kb fragments. Hence, the fragment that
spans the region between the EcoRV site (0.26 kb upstream
from the internal HindIII site) and the internal HindIII site
lies within the gtfA coding sequence.
We constructed a plasmid with the internal fragment of the
gtfA gene and an Emr determinant in two steps (Fig. 1).
Plasmid pYA601 was partially digested with HindIII and
ligated to a 1.7-kb fragment carrying the gene encoding the
Emr determinant (expressible in E. coli and S. mutans)
EH H H H
p RV
Isolate 1.7kb Emr
/ >4 gtfA fragment from pYA627
pYA601(monomer) HindM(partiol)
6.1kb H T4 DNA Ligose
FIG. 1. Construction of a plasmid with an Emr marker and an
internal fragment of the gtfA gene. Symbols: , DNA sequences
from original cloning vectors; E, Emr gene fragment from plasmid
pYA627; 1, S. mutans DNA sequence carrying the gtfA gene. The
relevant restriction sites are abbreviated as follows: E, EcoRI; H,
HindIII; Hp, HpaI; P, PstI; RV, EcoRV.
derived from plasmid pYA627 (3, 39). One Emr transformant
of strain X1849 contained the plasmid pYA682, which has the
1.36-kb HindIlI gtfA fragment adjacent to the Emr determi-
nant. This recombinant plasmid lost the 0.37-kb HindIII
fragment and did not express a functional GtfA protein. E.
coli strains carrying pYA682 did not generate reducing
sugars from sucrose. Plasmid pYA682 was further digested
with EcoRI and EcoRV and ligated to an EcoRI-HpaI digest
of plasmid pYA804 (W. R. Jacobs and R. E. Esser, unpub-
lished data). This plasmid vector carries pBR322 (6) se-
quences and a polylinker with multiple restriction sites and
was derived from plasmid pYA626 (10). Two E. coli strains,
X1849 (recombination proficient) and X2970 (recombination
deficient), were transformed with the ligation mixture; and
Tcr (12.5 p.g/ml) transformants were selected and screened
for resistance to erythromycin (500 ,ug/ml). The recombinant
plasmid isolated from X1849 transformants that encode re-
sistance to tetracycline and erythromycin was designated
pYA689 and was present as a mixture of monomeric and
multimeric forms. Clone X2970 transformants had the mono-
meric plasmid pYA690. Otherwise, both recombinant plas-
mids showed identical restriction patterns (data not shown).
Note that the EcoRV site from pYA682 and the HpaI site
from pYA804 were destroyed in the ligation to yield pYA689
or pYA690. Plasmids pYA301 (mixture of monomeric and
multimeric forms) and pYA302 (monomeric form) were
constructed by replacing the small EcoRI-HpaI fragment of
pYA804 with a 1.8-kb EcoRI-EcoRV fragment carrying the
Emr marker of pYA627 (R. J. Cook and R. G. Barletta,
unpublished data). Hence, pYA301 and pYA302 do not have
any homology with the chromosome. Note that plasmids
pYA301, pYA302, pYA689, and pYA690 did not carry an
active ,-lactamase gene (Apr determinant). This was an
important consideration in the design of the construction of
these vectors to be used in streptococci, which do not
naturally express resistance to penicillins.
Inactivation of the gtfA gene in S. mutans. Since plasmids
pYA689 and pYA690 are unable to replicate in S. mutans,
the Emr marker can be rescued only via an integration event
with the S. mutans chromosome. The mechanism of integra-
tion involves a recombination between the internal fragment
of the gtfA gene within pYA689 or pYA690 and the homol-
ogous gtfA gene in the S. mutans chromosome. This inser-
tion results in the inactivation of the gtfA gene by partial
duplication (Fig. 2).
We transformed two strains that were obtained as clinical
dental isolates, one contained an indigenous 5.8-kb plasmid
(UA101), and one was a plasmidless strain (UA130). We also
transformed strain MT8148, which is considered a typical
serotype c strain (41). Emr transformants were selected at
erythromycin concentrations that ranged from 1 to 25 ,u.g/ml.
Every transformant that was selected at a lower concentra-
tion was also able to grow at 25 ,ug/ml. Transformation
frequencies with the multimeric plasmid pYA689 were 20 to
30 times higher than were those with the monomeric plasmid
pYA690. No Emr transformants were obtained in a control
experiment in which donor DNA from plasmids pYA301 and
pYA302 was used to transform serotype c S. mutans strains.
Characterization of Emr GtfA- mutants. Two independent
Emr transformants from each S. mutans strain were chosen
for further study. PstI and EcoRV digests of chromosomal
DNA from wild-type and mutant strains were analyzed by
the Southern blotting procedure, with plasmid pYA601 used
as a probe.
The PstI digests of wild-type strains showed (Fig. 3A,
lanes 1, 4, 7, and 10) a unique 7.2-kb fragment with homol-
VOL. 56, 1988
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1- -8.1kb----
RV P H RV H H RV P
I,.I ,} I 1 tIf 1J..........I..
transformation, G 0
repair synthesis or
and recircularization pYA689\5.6kbIH
H
integration by
a single crossover
RV P H RVH HEHRV PH HRV P
. 12.8kb--- .--------9
,A.__- -----13.7kb .-- ----
FIG. 2. Inactivation scheme for S. mutans gtfA insertion-dupli-
cation mutants. Symbols: -, DNA sequences from original
cloning vectors; *, Em' gene fragment; E, S. mutans coding
sequences for the gtfA gene that are not duplicated; 1, coding
sequences for the gtfA gene that are duplicated; O, gtfA flanking
sequences; -----, crossover regions. The relevant restriction sites are
abbreviated as follows: E, EcoRI; H, HindlIl; P, PstI; RV, EcoRV.
A
4; * , - I
Kt)
m_
* - 1.36
- 0.37
ogy to the probe. Mutant strains UAB744, UAB746,
UAB747, UAB754, and UAB755 showed (Fig. 3A, lanes 2,
3, 5, 8, and 9, respectively) two homologous fragments of 8.1
and 4.6 kb, which adds to 12.7 kb, as was expected for the
insertion of one copy (monomer) of the 5.6-kb plasmids
pYA689 or pYA690 (which both have a unique PstI site)
within the gtfA gene (Fig. 2). From the location of the PstI
site in plasmids pYA689 or pYA690, we conclude that the
8.1-kb PstI fragment carries the 5'-end sequences of the gtfA
gene. Mutant strain UAB751 showed the same 4.6-kb ho-
mologous fragment and another 14-kb fragment (Fig. 3A,
lane 6) which hybridized to the probe. This result reveals a
polymorphism in the closest PstI site in the flanking se-
quences upstream from the gtfA gene. Note that the inser-
tion of a dimer of pYA689 or pYA690 would have generated
(on digestion with PstI) an intact monomer of these plasmids
and, hence, a 5.6-kb hybridizable fragment.
The EcoRV patterns of wild-type strains showed (Fig. 3B,
lanes 1, 4, 7, and 10) two homologous fragments of 7.5 and
0.6 kb that hybridized to the probe (note that the gtfA gene
has an internal EcoRV site). Insertion of pYA689 or pYA690
(which both carry the EcoRV site from the pBR322-derived
tet gene) within the gtfA gene in the S. mutans chromosome
generated three fragments that added up to 13.7 kb (Fig. 2).
In close agreement, all mutant strains yielded three frag-
ments of 7.5, 2.2, and 3.9 kb (Fig. 3B, lanes 2, 3, 5, 6, 8, and
9). The intensities of the bands of hybridizing fragments
were proportional to the homologies between the respective
fragment and pYA601 (which also shared homology with
pYA689 and pYA690). An analogous pattern of hybridizable
fragments was obtained by using the 1.36-kb HindIII frag-
ment of the gtfA gene as a probe (data not shown), con-
firming the insertional inactivation of the S. mutans gtfA
gene in the mutant strains.
We further characterized the putative GtfA- mutants by
Western blot analysis of cellular extracts with GtfA antise-
rum. The E. coli clone y1849(pYA601) and the S. mutans
wild-type strains UA101 and UA130 showed a cross-reactive
B
1 2 3 4 5 6 7 8 9 10 11
k t)
*- 11.2
;44-36
- 1.36
* - 0.37
FIG. 3. Southern blotting analysis of PstI (A) and EcoRV (B)
digests of total DNA from wild-type S. mutans strains and their gtfA
mutants. Total DNA (approximately 1 ,ug) from various S. mutans
strains was digested and hybridized; pYA601 was used as a probe.
Lanes 1 to 10, UA101 (GtfA+), UAB744 (GtfA-), UAB746 (GtfA-),
UA130 (GtfA+), UAB747 (GtfA-), UAB751 (GtfA-), MT8148
(GtfA+), UAB754 (GtfA-), UAB755 (GtfA-), and UAB764
(GtfA+), respectively. Size standards (lane 11) were linearized
plasmid pYA629 (11.2 kbp) and pYA601 DNA digested with HindIIl
(4.36, 1.36, and 0.37 kb).
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FIG. 4. Western blot analysis of cellular protein fractions from
various S. mutans strains against GtfA antiserum. Cellular extracts
(approximately 5 ,ug of protein) were electrophoresed on 10%
polyacrylamide-SDS gels, transferred to nitrocellulose sheets, and
analyzed with GtfA antiserum. Lane 1, X1849(pYA601) (GtfA+;
original E. coli gtfA clone); lane 2, X1849(pYA682) (gtfA; truncated
gene); lanes 3 to 12, S. mutans strains UA101 (GtfA+), UAB744
(GtfA-), UAB746 (GtfA-), UA130 (GtfA+), UAB747 (GtfA-),
UAB751 (GtfA-), MT8148 (GtfA+), UAB754 (GtfA-), UAB755
(GtfA-), and UAB764 (GtfA+), respectively. Size standards are
indicated to the left.
band of 55 kDa that corresponded to the GtfA protein (Fig.
4, lanes 1, 3, and 6). The S. mutans wild-type strains MT8148
and UAB764 showed a cross-reactive band that corre-
sponded to a GtfA protein that was slightly larger, about 58
kDa (Fig. 4, lanes 9 and 12). The GtfA+ strains UAB90,
UAB62, and GS5 produced a 58-kDa GtfA protein (data not
shown). The E. coli subclone X1849(pYA682) showed a
cross-reactive 48-kDa band that corresponded to a truncated
GtfA protein (Fig. 4, lane 2). We expected from our inacti-
vation scheme (Fig. 2) that the mutant strains also had a
48-kDa truncated protein. However, we did not find any
cross-reactive material in the S. mutans gtfA mutants (Fig.
4, lanes 4, 5, 7, 8, 10, and 11). We think that the truncated
protein is unstable in S. mutans and is degraded by prote-
ases. In any event, the absence of cross-reactive GtfA
protein in the mutant strains is consistent with the inactiva-
tion of the gtfA gene. Furthermore, we analyzed a set of
mutant cell extracts in nondenaturing activity gels, and we
found no GtfA activity (data not shown).
Stability of g*gA mutants. The presence of a small duplica-
tion in these gtfA mutants might lead to a certain degree of
genetic instability. Strains were grown in BHI broth contain-
ing 25 ,ug of erythromycin per ml, and then were subcultured
for 100 generations in the same medium in the absence of the
antibiotic. Titers of the cultures were then determined on
BHI agar, and 200 colonies were tested on BHI agar con-
taining 25 ,ug of erythromycin per ml. Results indicated that
100% of the cells remained Emr. Hence, the mutants were
reasonably stable in the absence of antibiotic-selective pres-
sure, such that animal infectivity studies could be conducted
in the absence of continual selection for Emr microorga-
nisms.
However, some degree of variation in colony morphology
on BHI agar was observed (Table 1). For instance, strain
UA130 (smooth) gave rise to a rough colony morphology
gtfA mutant (UAB747), besides the expected smooth phe-
notype (UAB751). All mutants derived from strain MT8148
(rough) gave smooth colony types. This property is not
related to the gtfA mutation since we were able to obtain
smooth variants of MT8148 which otherwise behaved as
wild-type strains (e.g., UAB764).
Virulence of gtfA mutants in rats. The virulence of gtfA
mutants was first evaluated in germfree rats (Table 2). We
evaluated smooth areas (buccal scores) and areas of pits and
fissures (sulcal scores). The buccal scores represent a true
evaluation of the ability of bacteria to adhere to hard
surfaces. The sulcal scores evaluate the selective coloniza-
tion of S. mutans in areas where food residues are prone to
accumulate. All strains exhibited caries scores that were
characteristic of cariogenic bacteria. In these experiments, a
very low level of caries was observed in control, noninfected
animals. S. mutans strains with decreased virulence exhibit
buccal and sulcal scores that are at most one-half the values
reported in Table 2 for strain MT8148 (12). No differences
were observed in rats infected with UA101, UAB744, and
UAB746 or with UA130, UAB747, and UAB751. Strains
MT8148 and UAB754 and the wild-type smooth colony
morphology variant UAB764 exhibited the highest viru-
lence. Higher numbers of S. mutans microorganisms were
recovered from animals infected with UAB764 than from
those infected with UAB754, although we observed no
difference in caries activity. Strain UAB755 was the least
virulent in the group of strains derived from MT8148. There
was some variation in the number of S. mutans cells isolated
from individual animals (Table 2).
Cultures from infected rats were streaked for isolated
colonies on BHI agar plates, and 100 colonies per strain were
tested for erythromycin resistance. All colonies from mutant
TABLE 2. Virulence of gtfA mutants in germfree rats
Mean caries scorea
Mean no. of
Strain No. of rats/group Buccal Sulcal Mean body S. mutanswt (g) CFU/mandible
Enamel Dentinal Dentinal Dentinal (107)slight slight moderate
UA101 6 11.2 ± 1.5 7.6 ± 1.3 9.0 ± 1.5 1.6 ± 0.7 104 ± 6 5.2 ± 2.8
UAB744 6 10.2 ± 1.8 7.6 ± 1.2 7.6 ± 2.0 1.2 ± 0.7 120 ± 4 5.5 ± 1.4
UAB746 6 9.6 ± 0.4 6.6 ± 0.4 8.6 ± 0.5 1.6 ± 0.4 121 ± 8 8.3 ± 2.5
UA130 6 11.6 ± 1.2 8.0 ± 1.1 9.8 ± 0.7 4.0 ± 0.8 139 ± 8 5.6 ± 1.7
UAB747 6 11.6 ± 0.7 8.4 ± 0.7 10.4 ± 0.8 4.2 ± 0.4 142 ± 6 4.8 ± 2.3
UAB751 6 11.2 ± 0.5 7.6 ± 0.5 10.2 ± 0.4 5.2 ± 0.2 157 ± 8 5.5 ± 1.8
MT8148 6 13.8 ± 1.1 9.0 ± 0.9 11.8 ± 0.4 3.9 ± 0.7 113 ± 6 1.0 ± 0.2
UAB754 6 12.6 ± 0.8 6.8 ± 0.9 10.6 ± 0.7 5.2 ± 0.7 103 ± 5 1.8 + 0.8
UAB755 6 10.6 ± 0.4 5.6 ± 0.5 9.4 ± 0.5 3.2 ± 0.2 104 ± 2 3.8 ± 0.9
UAB764 6 13.4 ± 1.2 8.4 ± 0.9 9.8 ± 1.3 4.0 ± 0.5 105 ± 4 9.2 ± 3.4
a Values are the means + standard error of the mean as determined by the method described by Keyes (24), as described previously (34).
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TABLE 3. Virulence of gtfA mutants in conventional rats
Mean caries score'
Mean no. of S.
Strain No. of rats/group Buccal Sulcal Mean body mutanswt (g) CFU/mandible
Enamel Dentinal Dentinal Dentinal (107)
slight slight moderate
MT8148 7 16.3 ± 1.2 8.0 ± 0.7 8.2 ± 0.8 3.0 ± 0.7 150 ± 8 11.6 ± 2.7
UAB754 8 13.5 ± 1.0 9.5 ± 0.7 9.1 ± 0.9 4.1 ± 0.5 157 ± 7 13.7 ± 2.4
UAB755 7 11.1 ± 1.2 7.3 ± 1.0 7.3 ± 1.1 2.0 ± 0.7 184 ± 13 9.4 ± 2.4
UAB764 8 14.6 ± 1.6 9.2 ± 1.1 7.5 ± 1.0 3.8 ± 0.7 165 ± 9 10.8 ± 3.0
a Values are the means + standard error of the mean as determined by the Keyes procedure (24), and described previously (34).
strains were Emr, indicating that the pYA689 or pYA690
insertion was stable during colonization and growth of the
microorganisms in rats. Furthermore, the virulence of gtfA
mutant strains UAB754 and UAB755 was tested in germfree
rats provided with 25 jig of erythromycin per ml in the
drinking water. The Emr strain MT8148(pYA629) was used
as a wild-type control. The results obtained agreed with the
results reported above: the three strains had the same
virulence potential (data not shown).
Germfree rats may not be the best environment in which
to compare wild-type and mutant strains, since the infecting
microorganism does not have to compete with the normal
oral flora. Therefore, we decided to evaluate the virulence of
mutants and parents in conventional rats. In this study, only
the group of strains derived from strain MT8148 were
analyzed. We obtained a similar pattern of activity (Table 3)
to that reported above for germfree rats. S. mutans cultures
recovered from rats infected with the mutant strains had an
Emr phenotype (100 colonies tested per strain). Hence, gtfA
mutants are virulent in both germfree and conventional rats.
DISCUSSION
Recombinant DNA technology provides a powerful way
of generating specific mutations in a target gene. We com-
bined an in vitro recombinant DNA procedure with an in
vivo recombination strategy. This methodology provides for
the direct selection of the mutant strain, since the mutant
phenotype is linked to the inheritance of an antibiotic
resistance marker. We chose to inactivate the gtfA gene by
inserting a plasmid that carries an internal region of the gene.
We based our procedure on a strategy that has been suc-
cessfully used to mutagenize Bacillus subtilis (16, 40) and
Streptococcus pneumoniae (37). The insertion of the plasmid
within the coding sequence of the gene resulted in gene
inactivation. The mutant strain also acquired a duplication of
the gene sequences that were present in the plasmid (Fig. 2).
In theory, any other streptococcal gene could be inactivated
in a similar fashion by subcloning an internal fragment of the
gene in the plasmid vectors pVA891 (32) or pYA301 (this
report), which belong to different E. coli incompatibility
groups. One advantage of this procedure is the potential to
obtain revertants to the wild-type phenotype (either due to a
true reversion of the mutated gene or to a suppressor
mutation), a procedure that is especially useful with muta-
tions that have a pleiotropic effect. Then, it is possible to
analyze whether the reversion of a trait is accompanied by
reversion of other traits. In this regard, we found that
inactivation of the gtfA gene also results in loss of the ability
of the mutant strains to use melibiose as a carbon source
(R. G. Barletta, S. M. Michalek, and R. Curtiss III, Abstr.
Annu. Meet. Am. Soc. Microbiol. 1987, D77, p. 84; R. G.
Barletta, Ph.D. thesis, University of Alabama at Birming-
ham, 1987). One disadvantage of this insertion-duplication
strategy is the instability of the mutant strains. An alterna-
tive approach, which precludes the isolation of true rever-
tants but ensures mutant strain stability, is the direct re-
placement of the wild-type gene with the inactivated gene (1,
31). The inactivated gene is usually constructed by replacing
an internal coding sequence with an antibiotic resistance
marker. Then, a double recombination event within se-
quences that flank the gene generates a deletion mutation.
This technique has also been successfully applied to the
inactivation of the S. mutans gtfA gene (43).
We also showed that a small region of homology (0.26 kb
in our case) is sufficient to obtain recombination in S.
mutans. The higher transformation frequency of the multi-
meric plasmid pYA689 compared with that of the monomeric
plasmid pYA690 was consistent with the transformation
mechanisms proposed for S. mutans (30) and S. pneumoniae
(46). The multimeric form would be able to transform the
strains by first-order kinetics, as opposed to the second-
order kinetics followed by the monomeric form. The cutting
of double-stranded DNA molecules at the cell surface,
followed by repair synthesis and recircularization, would
most likely lead to the formation of plasmid monomers. We
would then expect the integration of one copy of the plasmid
into the chromosome, as was observed.
Results of Southern blotting analysis showed the excision
of the gtfA gene into two fragments, as was expected by the
proposed recombination mechanism (Fig. 2). Further proof
of the gene inactivation was obtained by Western blotting
analysis of cell extracts against GtfA antiserum. The mutant
strains did not produce any cross-reactive material.
One interesting feature revealed by the Western blotting
studies was the heterogeneity of GtfA proteins displayed by
S. mutans GtfA+ strains, which were either 55 or 58 kDa.
The protein produced by the E. coli recombinant clone
X1849(pYA601) was 55 kDa. The smaller size of the GtfA
protein produced by recombinant E. coli can be accounted
for if the DNA sequence that codes for the C terminus of the
GtfA protein is not cloned within the S. mutans insert of
pYA601 (strain UAB90, the DNA of which was used for the
cloning experiments, produced a 58-kDa GtfA protein).
However, this does not explain why the smaller-sized frag-
ment (55 kDa) is also found in the wild-type S. mutans
strains UA101 and UA130. One possibility would be that
GtfA proteins from these two strains might differ slightly in
amino acid sequence, which could then lead to different
degrees of proteolytic breakdown. Proteases were found to
be responsible for extensive cell surface breakdown of
dextranase in S. sorbrinus (2). In this regard, some faint
bands (which were detectable after a longer photographic
film exposure; data not shown) that corresponded to putative
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degradation products of GtfA were observed in blots from
cell extracts of GtfA+ strains. Alternatively, the gtfA DNA
sequences in strains UA101 and UA130 might have mutated
to give rise to a termination codon, resulting in the 55-kDa
GtfA protein. DNA sequence analysis of the gtfA gene will
reveal which of these possibilities is correct.
In our studies with S. mutans gtfA mutants generated by
the recombinant DNA strategy described above, we found
that the gtfA mutants were as virulent in germfree and
conventional rats as they were in the wild-type strains. This
is, to our knowledge, the first report on the use of engineered
strains of S. mutans for the evaluation of pathogenicity in an
animal model system. Thus, the gtfA gene is not a major
virulence determinant. However, these results do not rule
out the involvement of the GtfA enzyme in pathogenesis. A
microorganism may have alternate routes of colonization
and of causing disease. Studies of multiple engineered mu-
tant strains are needed to evaluate the interaction and
cooperation of the various gene products.
Previous results from our laboratory and by Pucci and
Macrina (42-44) suggest that the GtfA enzyme may synthe-
size a primer for mutansucrase. The GtfA enzyme synthe-
sizes a small glucan (44) that is probably a-(1,3)-linked (R. G.
Barletta, Ph.D. thesis) when sucrose is used as the substrate.
Extracellular protein fractions of S. sanguis strains carrying
the gtfA gene showed increases in water-insoluble glucan
synthesis compared with that in wild-type strains (42); and
extracellular protein fractions of S. mutans gtfA deletion
mutants synthesized a lower amount of water-soluble glu-
cans, but the same amount of water-insoluble glucans,
compared with those of wild-type strains (43). These results
suggest that the GtfA enzyme synthesizes a glucan primer
which could be a substrate for mutansucrase. Thus, double
mutants in the gtfA gene, and the dextransucrase(s) or
dextranase(s) genes (which abolish production of the en-
zymes that are involved in the synthesis of putative primers
for mutansucrase) are the most likely candidates to reveal
the importance of the gtfA gene in virulence.
With regard to the discussion presented above, we also
note the following. (i) Dextranase and dextransucrase gen-
erate a-(1,6)-glucan polymers, but GtfA generates an a-(1,3)-
glucan (if GtfA generates a primer for mutansucrase; this
implies that mutansucrase can use either type of glucan as a
primer). (ii) Since S. mutans gtfA mutants are fully virulent,
we predict that mutant and wild-type strains synthesize
water-insoluble glucans with similar structures. (iii) The
exopolysaccharide synthesis assays performed by Pucci and
Macrina (43) are inadequate to assess the function of the
GtfA enzyme, since the GtfA enzyme is predominantly cell
bound and little enzyme is released into the culture super-
natant fluids of S. mutans cultures (44). The decrease in the
synthesis of water-soluble glucans in S. mutans gtfA mutant
strains, which was observed by Pucci and Macrina (43),
could then be an indirect effect resulting from the reduced
secretion of dextransucrase.
Studies on the virulence of nonengineered mutants from
the S. mutans group have been reported and reviewed pre-
viously (11). In this regard, mutants that are devoid of the
major surface antigen SpaA are completely avirulent (12, 13).
Mutants that are defective in dextranase also show reduced
virulence (50), as do S. sobrinus mutants that are defective in
insoluble glucan synthesis (36). Mutants that are defective in
the synthesis of intracellular polysaccharides have also been
shown to have reduced virulence (4), as do mutants that are
devoid of lactate dehydrogenase (23). On the other hand,
defects in dextran-induced aggregation have little effect on
cariogenicity (18, 20). Results of the studies on the virulence
of gtfA mutants, in concert with those of other investigations
on the virulence of mutants, will contribute to the identity of
the role and interactions of the various determinants that are
responsible for caries production by S. mutans.
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